153 related articles for article (PubMed ID: 30357709)
1. B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.
Naumnik W; Panek B; Ossolińska M; Naumnik B
Adv Exp Med Biol; 2019; 1150():11-16. PubMed ID: 30357709
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Osteoprotegerin and sRANKL in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer.
Naumnik W; Płońska I; Ossolińska M; Nikliński J; Naumnik B
Adv Exp Med Biol; 2018; 1047():1-6. PubMed ID: 29052177
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Adv Exp Med Biol; 2013; 788():341-8. PubMed ID: 23835996
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
Naumnik W; Naumnik B; Niklińska W; Ossolińska M; Chyczewska E
Adv Exp Med Biol; 2016; 952():41-49. PubMed ID: 27573644
[TBL] [Abstract][Full Text] [Related]
8. GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.
Edelman MJ; Feliciano J; Yue B; Bejarano P; Ioffe O; Reisman D; Hawkins D; Gai Q; Hicks D; Serrero G
Hum Pathol; 2014 Sep; 45(9):1893-9. PubMed ID: 25033727
[TBL] [Abstract][Full Text] [Related]
9. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Exp Oncol; 2012 Dec; 34(4):348-53. PubMed ID: 23302994
[TBL] [Abstract][Full Text] [Related]
10. Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?
Taci Hoca N; Ünsal E; Murat K; Ertürk A; Çapan N
Monaldi Arch Chest Dis; 2022 Nov; 93(3):. PubMed ID: 36382807
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
Bugdayci G; Kaplan T; Sezer S; Turhan T; Koca Y; Kocer B; Yildirim E
Exp Oncol; 2006 Jun; 28(2):169-71. PubMed ID: 16837913
[TBL] [Abstract][Full Text] [Related]
15. Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.
Lv D; Tan L; Zhang Q; Ma H; Zhang Y; Zhang Q; Yu Y; Chen Z; Ding Q; Deng Z
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775896
[TBL] [Abstract][Full Text] [Related]
16. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():136-45. PubMed ID: 9337532
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.
Smith JR; Braziel RM; Paoletti S; Lipp M; Uguccioni M; Rosenbaum JT
Blood; 2003 Feb; 101(3):815-21. PubMed ID: 12393412
[TBL] [Abstract][Full Text] [Related]
20. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
